All Publications

Export 160 results:
Author Title Type [ Year(Asc)]
Emergence of the H208Y mutation in the reverse transcriptase (RT) of HIV-1 in association with nucleoside RT inhibitor therapy. Nebbia G, Sabin C, Dunn D and Geretti A. J Antimicrob Chemother, 2007 May, Volume 59, Issue 5, p.1013-6, (2007)
Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failures. Benzie A, Bansi L, Sabin C, Portsmouth S, Hill T, Johnson M, Gilson R, Easterbrook P, Gazzard B, Fisher M et al. AIDS, 2007 Jul 11, Volume 21, Issue 11, p.1423-30, (2007)
Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study. Phillips A, Leen C, Wilson A, Anderson J, Dunn D, Schwenk A, Orkin C, Hill T, Fisher M, Walsh J et al. Lancet, 2007 Dec 08, Volume 370, Issue 9603, p.1923-8, (2007)
Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count. Phillips A, Gazzard B, Gilson R, Easterbrook P, Johnson M, Walsh J, Leen C, Fisher M, Orkin C, Anderson J et al. AIDS, 2007 Aug 20, Volume 21, Issue 13, p.1717-21, (2007)
CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003. Stöhr W, Dunn D, Porter K, Hill T, Gazzard B, Walsh J, Gilson R, Easterbrook P, Fisher M, Johnson M et al. HIV Med, 2007 Apr, Volume 8, Issue 3, p.135-41, (2007)
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts. Mocroft A, Staszewski S, Weber R, Gatell J, Rockstroh J, Gasiorowski J, Panos G, Monforte A, Rakhmanova A, Phillips A et al. Antivir Ther, 2007, Volume 12, Issue 3, p.325-33, (2007)
The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort study. Smith C, Phillips A, Hill T, Fisher M, Gazzard B, Porter K, Gilson R, Easterbrook P, Matthias R, Scullard G et al. J Infect Dis, 2005 Oct 15, Volume 192, Issue 8, p.1387-97, (2005)
Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study. Sabin C, Hill T, Lampe F, Matthias R, Bhagani S, Gilson R, Youle M, Johnson M, Fisher M, Scullard G et al. BMJ, 2005 Mar 26, Volume 330, Issue 7493, p.695, (2005)
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. Phillips A, Dunn D, Sabin C, Pozniak A, Matthias R, Geretti A, Clarke J, Churchill D, Williams I, Hill T et al. AIDS, 2005 Mar 25, Volume 19, Issue 5, p.487-94, (2005)